IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 101 a 120 di 370
Titolo Data di pubblicazione Autore(i) File
Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era. 1-gen-2009 Minisini, Am; Menis, J; Valent, F; Andreetta, C; Alessi, B; Pascoletti, G; Piga, Andrea; Fasola, G; Puglisi, Fabio
Capecitabina nel trattamento del carcinoma mammario metastatico: evidenza scientifica e impiego clinico 1-gen-2010 Puglisi, Fabio
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer 1-gen-2010 Venturini, M; Bighin, C; Puglisi, Fabio; Olmeo, N; Aitini, E; Colucci, G; Garrone, O; Paccagnella, A; Marini, G; Crinò, L; Mansutti, M; Baconnet, B; Barbato, A; Del Mastro, L.
Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. 1-gen-2010 Puglisi, Fabio
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. 1-gen-2010 D. W., Miles; A., Chan; L. Y., Dirix; J., Cortés; X., Pivot; P., Tomczak; T., Delozier; J. H., Sohn; L., Provencher; Puglisi, Fabio; N., Harbeck; G. G., Steger; A., Schneeweiss; A. M., Wardley; A., Chlistalla; G., Romieu
First-line chemotherapy with or without biologic agents for metastatic breast cancer 1-gen-2010 Andreetta, C; Minisini, Am; Miscoria, M; Puglisi, Fabio
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM) 1-gen-2010 Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Beretta, Gd; Caffo, O; Caroti, C; Crinò, L; De Laurentiis, M; Dinota, A; Di Vito, F; Gebbia, V; Giustini, L; Graiff, C; Guida, M; Lelli, G; Lombardo, M; Muggiano, A; Puglisi, F; Romito, S; Salvagno, L; Tagliaferri, P; Terzoli, E; Venturini, M
Hormone therapy in elderly breast cancer patients with comorbidities 1-gen-2010 Crivellari, D; Spazzapan, S; Puglisi, Fabio; Fratino, L; Scalone, S; Veronesi, A.
Guida alla gestione della terapia nelle pazienti con carcinoma mammario HER2+ 1-gen-2011 Amadori, D; Barni, S; Bisagni, G; Cinieri, S; Crivellari, D; De Laurentiis, M; De Placido, S; De Vita, F; Del Mastro, L; Di Leo, A; Fabi, A; Ferraù, F; Frassoldati, A; Gamucci, T; Gori, S; Lorusso, V; Marchetti, P; Molino, A; Montemurro, F; Morandi, P; Musolino, A; Mustacchi, G; Nisticò, C; Perrone, F; Pronzato, P; Puglisi, Fabio; Tondini, C. A.; Tortora, G; Venturini, M; Zamagni, C.
Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making? 1-gen-2011 Puglisi, Fabio; Minisini, A. M.
Treatment of HER2-positive breast cancer: current status and future perspectives 1-gen-2011 Arteaga, Cl; Sliwkowski, Mx; Osborne, Ck; Perez, Ea; Puglisi, Fabio; Gianni, L.
Epidemiologia, Cancerogenesi, Prevenzione e Screening 1-gen-2011 Piga, A; Puglisi, Fabio; Belvedere, O; Aprile, G.
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. 1-gen-2011 Puppin, Cinzia; Puglisi, Fabio; Pandolfi, M; DI LORETO, Carla; Damante, Giuseppe
B-cell lymphoma presenting as acute pancreatitis 1-gen-2011 Federico, E; Falconi, M; Zuodar, G; Falconieri, G; Puglisi, Fabio
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. 1-gen-2011 F., Cuppone; E., Bria; V., Vaccaro; Puglisi, Fabio; A., Fabi; I., Sperduti; P., Carlini; M., Milella; C., Nisticò; M., Russillo; P., Papaldo; G., Ferretti; M., Aapro; D., Giannarelli; F., Cognetti
Thymidine phosphorylase expression in metastatic kidney cancer as a potential predictor of outcome in patients treated with sunitinib 1-gen-2012 Miscoria, M.; DI LORETO, Carla; Puglisi, Fabio; Murray, P. G.; Deroma, L.; Atmadini, M.; Messahel, S.; Fasola, G.; James, N. D.; Porfiri, E.
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 1-gen-2012 Poletto, M; DI LORETO, Carla; Marasco, D; Poletto, E; Puglisi, Fabio; Damante, Giuseppe; Tell, Gianluca
Overcoming treatment resistance in HER2-positive breast cancer: potential strategies. 1-gen-2012 Puglisi, Fabio; Minisini, A. M.; Angelis, C. D.; Arpino, G.
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study 1-gen-2012 Pestrin, M; Bessi, S; Puglisi, Fabio; Minisini, Am; Masci, G; Battelli, N; Ravaioli, A; Gianni, L; Di Marsico, R; Tondini, C; Gori, S; Coombes, Cr; Stebbing, J; Biganzoli, L; Buyse, M; Di Leo, A.
Expression of Dicer and Drosha in triple-negative breast cancer 1-gen-2012 Passon, N; Gerometta, A; Puppin, C; Lavarone, E; Puglisi, Fabio; Tell, Gianluca; DI LORETO, Carla; Damante, Giuseppe
Mostrati risultati da 101 a 120 di 370
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile